Friday, 14 October 2016

Potential Therapy, Laquinimod, Shows Promise as Progressive MS Treatment in Mouse Study.

Source Multiple Sclerosis News Today:

The experimental therapy laquinimod was seen to prevent the start of harmful immune responses and to disrupt the progression of multiple sclerosis (MS) in a mouse model of the disease. This finding may be especially promising, as the treatment is being developed for people with both relapsing MS and its rarer progressive form, for which no treatment currently exists.  Read on.